Status:
COMPLETED
Study Evaluating SKI-606 Administered to Healthy Subjects
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
Safety and tolerability of SKI-606 in healthy subjects; the influence of food intake on the same.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Healthy
Exclusion
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00406406
Start Date
November 1 2006
End Date
August 1 2007
Last Update
December 5 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Utrecht, Netherlands, 3584 CJ